Amphastar Pharmaceuticals, Inc. (AMPH)
25.95
-0.12
(-0.46%)
USD |
NASDAQ |
Jan 20, 16:00
25.95
0.00 (0.00%)
After-Hours: 20:00
Amphastar Pharmaceuticals Shareholders Equity (Quarterly): 776.75M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Eli Lilly & Co. | 23.79B |
| Pfizer Inc. | 92.80B |
| Supernus Pharmaceuticals, Inc. | 1.050B |
| Catalyst Pharmaceuticals, Inc. | 920.24M |
| CorMedix, Inc. | 374.13M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.666B |
| Total Liabilities (Quarterly) | 889.48M |
| Debt to Equity Ratio | 0.8455 |
| Current Ratio | 3.116 |
| Net Debt Paydown Yield | -0.59% |